BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19692100)

  • 1. Parallel evolutions of the growth rate of newly diagnosed HIV cases and the proportion of potentially infective patients in Cayenne French Guiana: should HAART be used to curb the epidemic?
    Nacher M; Vantilcke V; Huber F; El Guedj M; Vaz T; Magnien C; Djossou F; Mahamat A; Dabis F; Couppié P
    Public Health; 2009 Aug; 123(8):573-4. PubMed ID: 19692100
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.
    Lima VD; Johnston K; Hogg RS; Levy AR; Harrigan PR; Anema A; Montaner JS
    J Infect Dis; 2008 Jul; 198(1):59-67. PubMed ID: 18498241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for follow-up interruption of HIV patients in French Guiana.
    Nacher M; El Guedj M; Vaz T; Nasser V; Randrianjohany A; Alvarez F; Sobesky M; Magnien C; Couppié P
    Am J Trop Med Hyg; 2006 May; 74(5):915-7. PubMed ID: 16687702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Highly active antiretroviral therapy].
    Jablonowski H
    MMW Fortschr Med; 2009 Apr; 151(18):58-61. PubMed ID: 19769079
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-HIV agents. Should HAART begin right after an HIV diagnosis?
    TreatmentUpdate; 2009; 21(3):2-3. PubMed ID: 19630120
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased incidence of leprosy following HAART initiation: a manifestation of the immune reconstitution disease.
    Couppié P; Domergue V; Clyti E; El Guedj M; Vaz T; Sainte-Marie D; Marty C; Nacher M
    AIDS; 2009 Jul; 23(12):1599-600. PubMed ID: 19487911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased incidence of mucosal candidiasis after HAART initiation: a benign form of immune reconstitution disease?
    Nacher M; Vantilcke V; Huber F; Mahamat A; El Guedj M; Randrianjohany A; Clyti E; Aznar C; Carme B; Couppié P
    AIDS; 2007 Nov; 21(18):2534-6. PubMed ID: 18025892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
    Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
    Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
    Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
    Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrition. Study finds vitamin B12 levels low in some HAART users.
    TreatmentUpdate; 2003 Oct; 15(6):6-7. PubMed ID: 17216864
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in the European HIV/AIDS epidemic: a perspective from Italy.
    Madeddu G; Rezza G; Mura MS
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):25-36. PubMed ID: 19622055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications & side effects. HAART and bones-mixed messages.
    TreatmentUpdate; 2007; 19(4):3-5. PubMed ID: 17969257
    [No Abstract]   [Full Text] [Related]  

  • 13. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
    de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
    J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Highly active antiretroviral therapy. Building on experience in developing new strategies].
    Paukstadt W
    MMW Fortschr Med; 2011 May; 153(18):39. PubMed ID: 21604595
    [No Abstract]   [Full Text] [Related]  

  • 16. Country of infection among HIV-infected patients born abroad living in French Guiana.
    Nacher M; Adriouch L; Van Melle A; Parriault MC; Adenis A; Couppié P
    PLoS One; 2018; 13(2):e0192564. PubMed ID: 29420591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Also consider cardiovascular risk. Every HIV patient "his" HAART].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():58-60. PubMed ID: 19031565
    [No Abstract]   [Full Text] [Related]  

  • 18. Temporal trend of the proportion of patients presenting with advanced HIV in French Guiana: stuck on the asymptote?
    Nacher M; Huber F; Adriouch L; Djossou F; Adenis A; Couppié P
    BMC Res Notes; 2018 Nov; 11(1):831. PubMed ID: 30477588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic and diagnostic advances in the HAART era.
    Cheng B
    Res Initiat Treat Action; 2005; 11(1):42-5. PubMed ID: 16208819
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana.
    Huber F; Nacher M; Aznar C; Pierre-Demar M; El Guedj M; Vaz T; Vantilcke V; Mahamat A; Magnien C; Chauvet E; Carme B; Couppié P
    AIDS; 2008 May; 22(9):1047-53. PubMed ID: 18520348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.